Omid Farokhzad, MD
- CEO & Founder of Seer Inc.
- Founded 5 nanoparticle companies: BIND, Selecta, Placon, TARVEDA, Seer
- Harvard Medical School Professor
- 5th Mustafa Prize Winner
Dong Jin Joo, MD, Ph.D.
Author of Bilirubin Thesis
- Yonsei Medical School Professor (Transplantation surgery)
- Director of Liver Transplantation Center, Severance Hospital
- Performed over 1,000 liver transplant surgeries
- Korean society of transplantation (BOD)
- Publication on the correlation between serum Bilirubin levels and graft survival rates in kidney transplantation
Peter M. Kang, MD
Author of Bilirubin Thesis
- Harvard Medical School Professor
- Director of Cardiovascular Physiology Core, Beth Israel Deaconess Medical Center
- Study on in vivo efficacy of Brixelle for renal warm IRI
- Publication on the efficacy of Brixelle in IRI induced by AMI
Beom Seok Kim, MD, Ph.D.
- Professor of Nephrology, Yonsei University; Director, Nephrology Center; Head of Department.
- Specialist in CKD, dialysis, renal transplantation and glomerular disease.
- Published over 140 papers
- President‑elect, Korean Society for Transplantation (from Nov 2025); Director, Examination Board, Korean Medical Association; Board Member, Korean Society for Xenotransplantation.
Ju Han Lee, MD, Ph.D.
Author of Bilirubin Thesis
- Yonsei Medical School Professor (Transplantation surgery)
- Director of Kidney Transplantation Center, Severance Hospital
- Korean society of transplantation, American Society of Transplantation
- Publication on in vivo efficacy study of Brixelle for Myocadiac IRI
- Publication on in vivo efficacy study of Brixelle for Heart Transplantation
John Neylan, MD
- CMO at Akari Therapeutics, Angion Biomedica, Keryx Biopharmaceuticals.
- Senior Vice President at Genzyme (Sanofi)
- Emory University School of Medicine Professor, UC Davis Assistant Professor
- American Society of Transplantation Chairman
- Harvard Medical School Clinical Fellow
Byung-Gun(BG) Rhee, Ph.D.
- PhD in Chemical Engineering from Rice University, B.S. from Seoul National University
- Chairman of the Korean Committee at the International Vaccine Institute
- Advisor at the Johns Hopkins University Innovation Center
- Special Advisor at Flagship Pioneering
- CEO of GC Pharma, CKD Pharma Holdings, and SCM Life Science, GI Innovation
Young Geun Shin, Ph.D.
Author of Bilirubin Thesis
- Chungnam National University Professor
- Over 20 years of experiences in pharmacokinetics (PK)
- More than 10 years of experience at Genentech & GSK
- Post-doc in Illinois at Chicago
- Publication on the efficacy of Brixelle for PK
Jae Seok Yang, MD, Ph.D.
Author of Bilirubin Thesis
- Yonsei Medical School Professor (Nephrology)
- Former Professor, Transplantation center, Seoul National University Hospital
- Publication on the efficacy of Brixelle for renal warm IRI
- Study on the efficacy of Brixelle for kidney transplantation